ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Ä¡·á À¯Çüº°, Ä¡·á ºÐ¾ßº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type ( Autologous Therapies, Non-Stem Cell Therapies, Non-Stem Cell Therapies), By Therapeutic Area (Oncology, Dermatology), By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1630942
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 22.01%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â¿¡´Â 182¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ï, ½Å°æÅðÇ༺ Áúȯ, ½ÉÇ÷°üÁúȯ, ÀÚ°¡¸é¿ªÁúȯ, Á¤Çü¿Ü°ú µîÀÇ Áúº´ ¹× Àå¾ÖÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀÔ´Ï´Ù. ¸¶Âù°¡Áö·Î, ÀÌ·¯ÇÑ Ä¡·á¹ýÀº ȯÀÚ À¯·¡ ¼¼Æ÷¿¡¼­ °³¹ßµÇ¾î ü³» ¼Õ»óµÈ Á¶Á÷ÀÇ Àç»ýÀ» Áö¿øÇϱ⠶§¹®¿¡ ÀÚ°¡ ¼¼Æ÷ Ä¡·á¸¦ ÅëÇÑ °ÅºÎ¹ÝÀÀÀÇ À§Çè °¨¼Ò´Â ½ÃÀå °³Ã´ÀÇ Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù.

COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È ½ÃÀåÀº ¿©·¯ °¡Áö ¾î·Á¿òÀ» °Þ¾ú°í, ȯÀÚµéÀº ¾ÈÀü ¹®Á¦·Î ÀÎÇØ ÀÚÅà ´ë±âÇØ¾ß Çß½À´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ£ ¿äÀÎÀ¸·Î´Â Á¦Á¶»óÀÇ Àå¾Ö¹°°ú º´¿øÀ¸·ÎÀÇ È¯ÀÚ À¯ÀÔ °¨¼Ò µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª COVID-19 ÀÌÈÄ, FDAÀÇ ½ÂÀΰú ´Ù¾çÇÑ ÀûÀÀÁõ¿¡ ´ëÇÑ »õ·Î¿î Ä¡·á¹ý °³¹ßÀÌ ÁøÇàµÇ¸é¼­ ½ÃÀå ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

2020³â 4¿ù, ÀÓ»ó ´Ü°èÀÇ »ý¸í°øÇÐ ±â¾÷ Èñ¸Á ¹ÙÀÌ¿À»çÀ̾ð½º(Hope Biosciences)´Â HB-adMSCs(Hope BioscienceÀÇ ÀÚ°¡ Áö¹æ À¯·¡ Áß°£¿± Áٱ⼼Æ÷)ÀÇ COVID-19¿¡ ´ëÇÑ ¸é¿ª Áö¿ø È¿´É°ú ¾ÈÀü¼ºÀ» Æò°¡ÇÏ´Â ÀÓ»ó 2»ó ½ÃÇè¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù. 2020³â 6¿ù, Chiesi ±×·ì°ú Holostem Terapie Avanzate´Â ¾È±¸ Ç¥¸é È­»ó ȯÀÚ¸¦ À§ÇÑ ÀÚ°¡ Áٱ⼼Æ÷ Ä¡·áÁ¦ÀÎ HoloclarÀÇ »ç¾÷ ¾çµµ¿¡ ÇÕÀÇÇß½À´Ï´Ù. ¾ç»ç´Â Àü·«Àû ¸ñÇ¥¿¡ ÁýÁßÇϰí Èñ±ÍÁúȯ¿¡ ´ëÇÑ Ä¡·á¹ý Á¢±ÙÀ» °¡¼ÓÈ­Çϱâ À§ÇØ À̹ø °è¾àÀ» ü°áÇß½À´Ï´Ù.

ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Ä¡·á À¯Çü ºñÁî´Ï½º ºÐ¼®

Á¦5Àå Ä¡·á ºÐ¾ß ºñÁî´Ï½º ºÐ¼®

Á¦6Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®

Á¦7Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Autologous Cell Therapy Market Growth & Trends:

The global autologous cell therapy market size is expected to reach USD 18.23 billion by 2030, registering a CAGR of 22.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing burden of diseases and disorders such as cancer, neurodegenerative disorders, cardiovascular disorders, autoimmune disorders, and orthopedics are the factors driving the demand for the market. Likewise, the reduced risk of autologous cell therapy rejection is one of the important factors for market growth as these therapies are developed from patient-derived cells and support the regeneration of the damaged tissues in the body.

During the COVID-19 pandemic, the market has witnessed various challenges where patients were restricted to stay at home due to safety concerns. Some factors that affected the market growth are manufacturing hurdles and reduced patient inflow in hospitals. However, post-COVID-19 the market has witnessed the demand for the market with FDA clearance and all of the new advances in treating a wide range of disease indications.

In April 2020, Hope Biosciences, a clinical-stage biotechnology company announced the FDA clearance for a phase II clinical trial evaluating the efficacy & safety of HB-adMSCs (Hope Bioscience' autologous, adipose-derived mesenchymal stem cells), to offer immune support against COVID-19. In June 2020, Chiesi Group and Holostem Terapie Avanzate mentioned the agreement for the transfer of the business branch Holoclar. The Holoclar is an autologous stem cell therapy for patients with ocular surface burns. It aims to allow both companies to focus on the strategic objective and accelerate procedures access for rare diseases.

Autologous Cell Therapy Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Autologous Cell Therapy Market Variables, Trends & Scope

Chapter 4. Therapy Type Business Analysis

Chapter 5. Therapeutic Area Business Analysis

Chapter 6. Regional Business Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â